Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth
- PMID: 3035060
- DOI: 10.1099/0022-1317-68-6-1563
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth
Abstract
The mechanism of action of 9-(1,3-dihydroxypropoxymethyl)guanine (DHPG) and phosphonoformic acid (PFA) but not 5-fluorouridinedeoxyribose (FUdR), provides selective action against cytomegalovirus (CMV)-coded events and this was used to demonstrate that the synthesis of viral DNA was continuous during the extended phase of virus growth. The synthesis de novo of viral DNA was measured by restriction enzyme analysis after exposure to [32P]orthophosphate and its interruption by DHPG or PFA resulted in a cessation in the extrusion of infective virus from treated cells. The rate of decline in infectivity appeared to correspond to the failure of cells to maintain the synthesis of late proteins once DNA synthesis was blocked. Thus, regulation of late protein synthesis appeared to be linked to synthesis de novo of viral DNA even at late stages in CMV growth. The synthesis of the polyamines spermidine and spermine, considered obligatory for CMV growth, was unaffected by early or late inhibition of viral DNA and this showed that some virus-induced events were unaffected by the restriction on virus growth by DHPG. This provided evidence that polyamine biosynthesis was a target independent of viral DNA synthesis per se, which may be important in future considerations of combined drug therapies.
Similar articles
-
Fine structure of cells infected with human cytomegalovirus after treatment with 9-(1,3-dihydroxy-2-propoxymethyl)guanine.J Gen Virol. 1987 Jun;68 ( Pt 6):1553-62. doi: 10.1099/0022-1317-68-6-1553. J Gen Virol. 1987. PMID: 3035059
-
In vitro inhibition of human herpesvirus-6 by phosphonoformate.J Virol Methods. 1988 Sep;21(1-4):301-4. doi: 10.1016/0166-0934(88)90075-4. J Virol Methods. 1988. PMID: 2972736
-
Screening with a shell vial assay for antiviral activity against cytomegalovirus.Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):5-8. doi: 10.1016/0732-8893(89)90036-9. Diagn Microbiol Infect Dis. 1989. PMID: 2540934
-
Polyamine metabolism in MRC-5 cells infected with human cytomegalovirus.J Gen Virol. 1980 May;48(1):183-91. doi: 10.1099/0022-1317-48-1-183. J Gen Virol. 1980. PMID: 6247434
-
Interactions of antiviral agents with viral DNA synthesis.Biochem Pharmacol. 1988 May 1;37(9):1789-90. doi: 10.1016/0006-2952(88)90447-9. Biochem Pharmacol. 1988. PMID: 3288216 Review. No abstract available.
Cited by
-
Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.PLoS One. 2017 Feb 9;12(2):e0171812. doi: 10.1371/journal.pone.0171812. eCollection 2017. PLoS One. 2017. PMID: 28182772 Free PMC article.
-
Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function.J Virol. 2004 Nov;78(21):11988-2011. doi: 10.1128/JVI.78.21.11988-12011.2004. J Virol. 2004. PMID: 15479839 Free PMC article.
-
Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence.J Virol. 2002 Dec;76(23):12135-48. doi: 10.1128/jvi.76.23.12135-12148.2002. J Virol. 2002. PMID: 12414954 Free PMC article.
-
Human cytomegalovirus infection inhibits G1/S transition.J Virol. 1997 Feb;71(2):1629-34. doi: 10.1128/JVI.71.2.1629-1634.1997. J Virol. 1997. PMID: 8995690 Free PMC article.
-
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.Drugs. 1990 Apr;39(4):597-638. doi: 10.2165/00003495-199039040-00008. Drugs. 1990. PMID: 2161731 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
